ECHDC3 and acute myeloid leukemia: Both bioinformatic analysis and experiment supported the role of ECHDC3 in mediating chemoresistance, and bioinformatic analysis suggested that ECHDC3 alters the BM microenvironment, which warranted further exploration of ECHDC3 in AML in near future.